Cargando…
Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients
OBJECTIVES: To evaluate the tolerance and effectiveness of stereotactic ablative radiotherapy (SABR) applied in the treatment of low and intermediate risk (LR & IR) prostate cancer patients (PCP) and provide an evaluation of the level of risk group impact on tr results. In addition, androgen dep...
Autores principales: | Miszczyk, Leszek, Kaletka, Agnieszka Namysł, Napieralska, Aleksandra, Woźniak, Grzegorz, Fudzińska, Małgorzata Stąpór, Głowacki, Grzegorz, Tukiendorf, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494208/ https://www.ncbi.nlm.nih.gov/pubmed/28545199 http://dx.doi.org/10.22034/APJCP.2017.18.4.1007 |
Ejemplares similares
-
CyberKnife-based prostate cancer patient radioablation – early results of irradiation in 200 patients
por: Miszczyk, Leszek, et al.
Publicado: (2015) -
Stereotactic Ablative Radiotherapy for Prostate Cancer—The Treatment Results
of 500 Patients and Analysis of Failures
por: Miszczyk, Leszek, et al.
Publicado: (2019) -
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
por: Miszczyk, Marcin, et al.
Publicado: (2022) -
Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate
Cancer: The Single-Center Experience
por: Miszczyk, Leszek, et al.
Publicado: (2018) -
The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson’s Disease—Phase II Study
por: Goc, Bartłomiej, et al.
Publicado: (2023)